middle.news
Control Bionics Secures FDA Registration for NeuroStrip Medical Device
8:26am on Tuesday 4th of August, 2026 AEST
•
Healthcare
Read Story
Control Bionics Secures FDA Registration for NeuroStrip Medical Device
8:26am on Tuesday 4th of August, 2026 AEST
Key Points
NeuroStrip officially registered as FDA medical device
Registration enhances clinical and research market credibility
Supports growth across performance, rehabilitation, and research applications
Pending regulatory approvals in Australia, EU, and UK underway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE